FDA Approves Remdesivir, a first for for COVID-19 Treatment
previously authorized for emergency use of remdesivir, as it is now specifically…
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
A participant in Neurogene's clinical trial for Rett syndrome gene therapy has…
Calls for political parties to prioritise overcrowding, alcohol harm and access to new medicines
Health groups in Ireland are urging the next government to address key…
Journalists Reflect on Trump Picks, Racism and Public Health, and Unnecessary Dental Implants
KFF Health News covered various health-related topics in interviews and projects. Julie…
Xipere demonstrates durability, safety in real-world setting
At the Retina Society meeting, Dr. Steven Yeh discussed the use of…
Biotech and pharma react with relief to Makary as FDA commissioner
Key figures in biotech, pharma, and medical devices were contacted by STAT…
Cancer: Health costs will become “unsustainable” without action, warns OECD
The OECD has called for urgent action to reduce the burden of…
New initiative aims to explore diet’s role in lupus care
Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, launched the…
First Long-Term Study ID’s Recovery Time for Brain Disorder
Recovery from anti-NMDAR encephalitis can take 3 years or more with lingering…